Rice Hall James & Associates, LLC Clovis Oncology, Inc. Transaction History

Rice Hall James & Associates, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$3.93 - $15.35 $817,648 - $3.19 Million	-208,053 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$12.81 - $25.67 $180,774 - $362,255	-14,112 Reduced 6.35%	208,053 $3.09 Million
Q1 2019 May 01, 2019	BUY	$17.66 - $30.28 $207,381 - $355,578	11,743 Added 5.58%	222,165 $5.51 Million
Q4 2018 Feb 14, 2019	BUY	$11.63 - $32.67 $711,872 - $2 Million	61,210 Added 41.02%	210,422 $3.78 Million
Q3 2018 Oct 25, 2018	SELL	$29.37 - $49.48 $144,001 - $242,600	-4,903 Reduced 3.18%	149,212 $4.38 Million
Q2 2018 Aug 02, 2018	BUY	$42.06 - $62.4 $253,874 - $376,646	6,036 Added 4.08%	154,115 $7.01 Million
Q1 2018 Apr 25, 2018	BUY	$50.12 - $67.72 $21,501 - $29,051	429 Added 0.29%	148,079 $7.82 Million
Q4 2017 Jan 23, 2018	BUY	$57.69 - $84.58 $1.5 Million - $2.2 Million	25,985 Added 21.36%	147,650 $10 Million
Q3 2017 Oct 30, 2017	BUY	$67.17 - $84.81 $8.17 Million - $10.3 Million	121,665	121,665 $10 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.